Literature DB >> 55586

A double-blind trial of the effect of wheat bran on symptoms of irritable bowel syndrome.

J Soltoft, B Krag, E Gudmand-Hoyer, E Kristensen, H R Wulff.   

Abstract

59 outpatients with irritable bowel syndrome participated in a randomised double-blind trial. The patients in the treatment group received three biscuits daily each containing 10 g of ordinary miller's bran, whereas the patients in the control group received wheat biscuits of a similar appearance. The treatment period was 6 weeks. 52% of the patients in the treatment group noted subjective improvement compared with 65% in the control group. The results of this trial do not support the routine use of miller's bran in irritable bowel syndrome.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 55586     DOI： 10.1016/s0140-6736(76)91402-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  26 in total

1.  British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome.

Authors:  J Jones; J Boorman; P Cann; A Forbes; J Gomborone; K Heaton; P Hungin; D Kumar; G Libby; R Spiller; N Read; D Silk; P Whorwell
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

2.  Long-term treatment with mesalazine in patients with symptomatic uncomplicated diverticular disease.

Authors:  Luigi Gatta; Francesco Di Mario; Margherita Curlo; Dino Vaira; Alberto Pilotto; Paolo Lucarini; Maurizio Lera; Kajo Enkleda; Angelo Franzé; Carmelo Scarpignato
Journal:  Intern Emerg Med       Date:  2011-01-29       Impact factor: 3.397

3.  The bulk of gastroenterology.

Authors:  R Rossman
Journal:  Can Fam Physician       Date:  1978-12       Impact factor: 3.275

4.  Efficacy of mesalazine in the treatment of symptomatic diverticular disease.

Authors:  Francesco Di Mario; Giovanni Aragona; Gioacchino Leandro; Giuseppe Comparato; Libera Fanigliulo; Lucas G Cavallaro; Giulia M Cavestro; Veronica Iori; Marta Maino; Alì M Moussa; Alessandro Gnocchi; Giancarlo Mazzocchi; Angelo Franzé
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

5.  The Irritable Colon: The Family Physician's Most Common Gastroenterological Dilemma.

Authors:  W W Rosser
Journal:  Can Fam Physician       Date:  1988-03       Impact factor: 3.275

6.  Is bran efficacious in irritable bowel syndrome? A double blind placebo controlled crossover study.

Authors:  M R Lucey; M L Clark; J Lowndes; A M Dawson
Journal:  Gut       Date:  1987-02       Impact factor: 23.059

Review 7.  The Importance and Challenges of Dietary Intervention Trials for Inflammatory Bowel Disease.

Authors:  James D Lewis; Lindsey Albenberg; Dale Lee; Mario Kratz; Klaus Gottlieb; Walter Reinisch
Journal:  Inflamm Bowel Dis       Date:  2017-02       Impact factor: 5.325

8.  Irritable bowel syndrome and upper dyspepsia among the elderly: a study of symptom clusters in a random 70 year old population.

Authors:  L Kay; T Jørgensen; K Schultz-Larsen; M Davidsen
Journal:  Eur J Epidemiol       Date:  1996-04       Impact factor: 8.082

Review 9.  Drug treatment of the irritable bowel syndrome.

Authors:  P L Pattee; W G Thompson
Journal:  Drugs       Date:  1992-08       Impact factor: 9.546

10.  Comparison of various treatments for irritable bowel syndrome.

Authors:  J A Ritchie; S C Truelove
Journal:  Br Med J       Date:  1980-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.